In the article that accompanies this editorial, 7 KEYNOTE-789, a randomized phase III trial of carboplatin- or cisplatin-pemetrexed-pembrolizumab versus carboplatin- or cisplatin-pemetrexed in 492 ...
Analysis of a real-world database showed that an EGFR exon 20 mutation occurred in fewer than 17% of patients with non-squamous NSCLC. Of patients with the mutation, fewer than 1% had an EGFR exon ...
EGFR-positive lung cancer is more common in non-smokers (particularly those with adenocarcinoma) and younger adults, as it often develops from a single genetic mutation rather than widespread DNA ...
The risk for acute kidney injury was not higher among patients with an eGFR dip at empagliflozin initiation. Previous studies have reported renal benefits with sodium glucose cotransporter 2 inhibitor ...
Please provide your email address to receive an email when new articles are posted on . Cystatin C-based eGFR had the smallest impact on eGFR values for Black patients with chronic kidney disease ...
Please provide your email address to receive an email when new articles are posted on . Rapid eGFR decline occurred in 23% of patients on high-intensity exercise. Meanwhile, rapid eGFR decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results